WednesdayJun 21, 2017 9:46 am

Algae Dynamics Corp. (ADYNF) is “One to Watch”

Algae Dynamics Corp (OTCQB: ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae. The original core of the company’s product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives…

Continue Reading

TuesdayJun 20, 2017 3:53 pm

InMed Pharmaceuticals, Inc. (IMLFF) is a Player in the Billion Dollar Cannabis Biotech Market

Despite the fire-breathing from Attorney-General Jefferson Beauregard Sessions III, there is a distinct feeling that marijuana has entered the mainstream now that Goldman Sachs has initiated coverage on GW Pharma (NASDAQ: GWPH). GW Pharma is the biopharmaceutical that developed the cannabinoid-derived Sativex to treat spasticity due to multiple sclerosis (MS), now approved by regulatory authorities in 29 countries. The success of GW Pharma and other pharmaceutical companies focused on cannabinoid research has produced an exciting new field with a lot of promise, cannabis biotech, and InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is staking a position in that emerging market.…

Continue Reading

MondayJun 19, 2017 2:41 pm

InMed Pharmaceuticals, Inc. (IMLFF) Gains Attention for Its Operational Developments and Leadership Team

InMed Pharmaceuticals, Inc. (OTCQB: IMLFF), a pre-clinical stage biopharmaceutical company that specializes in the development of therapies through research and development into the pharmacology of cannabinoids and drug delivery systems, continues to get positive media coverage of ongoing operational developments, propelled by the company’s impressive leadership team. Insider Financial highlighted InMed Pharmaceuticals as a “Cannabis Runner” in an article back in January, stating that “This is the kind of company that needs to maintain a positive news flow in order to keep investors interested.” More recently, Forbes released an article describing the company as “more than just another cannabis drug…

Continue Reading

ThursdayJun 15, 2017 11:23 am

SinglePoint, Inc. (SING) Using Bitcoin to Bypass Banking Roadblocks

A total of 29 states now allow for comprehensive medical marijuana programs, and recreational marijuana is legal in eight. There’s no question that the country’s opinion of marijuana has changed. Public support for making marijuana legal has continued to climb over the years, as 61 percent of Americans now think recreational use of marijuana should be legal and 88 percent favor medical marijuana use. A vast majority of the states and the citizens of this country support legalized marijuana in spite of antiquated federal government strictures. These antiquated federal strictures create conflict. The states where it has been legalized, the…

Continue Reading

ThursdayJun 15, 2017 8:00 am

Pharmaceutical Leaders Pave the Way to New Alzheimer’s Treatments

CBDWire Editorial Coverage: Alzheimer’s disease is a devastating brain disorder that now affects about 5.3 million Americans, accounting for one in nine people over the age of 65, according to the Alzheimer’s Association. One in three seniors die with the disease or another form of dementia, and, while treatments to slow or stop the disease’s progression have been lacking, several pharmaceutical companies are working to change that. India Globalization Capital, Inc. (NYSE: IGC) (IGC Profile), which has products that are backed by data  of cannabis-based combination therapies to treat Alzheimer’s, pain, seizures and a host of neurological and oncological issues,…

Continue Reading

WednesdayJun 14, 2017 9:00 am

Digital Currency Headed for Widespread Acceptance, Has Potential as Cure for Banking Concerns among Cannabis Companies

CBDWire Editorial Coverage: The cannabis market in the U.S. and worldwide continues to grow, but that doesn’t mean everyone is open to the idea of legal marijuana. The banking industry is one example, as the Federal Deposit Insurance Corporation (FDIC) has generally been unsupportive of backing cannabis-related investments. Since marijuana hasn’t been legalized at the federal level, most banks are hesitant to have any part of the $6.7 billion marijuana industry. While many industry experts expect this stance to change amid growing support for a bankable marijuana industry, 70 percent of cannabis companies currently operate without access to a corporate…

Continue Reading

TuesdayJun 13, 2017 2:20 pm

Significant Milestones Put Player’s Network (PNTV) on the Radar

It’s been an exciting few months for Player’s Network, Inc. (OTCQB: PNTV), and the markets have reacted with increased interest in this active diversified holding company, which recently recorded its first revenues (http://nnw.fm/q9VCj), received its state-issued medical marijuana licenses (http://nnw.fm/8AbNW), and commenced operations at its 27,000-square-foot marijuana facility in North Las Vegas. These and other major milestones achieved so far in 2017 make PNTV an exciting company to watch. In February, PNTV uplisted to the OTCQB Venture Market and paid down most of its outstanding debt. While PNTV says it has always been fully reporting, moving to the OTCQB increases…

Continue Reading

TuesdayJun 13, 2017 1:31 pm

ChineseInvestors.com, Inc. (CIIX) Participates In SeeThruEquity Microcap Investor Conference, Receives Research Report Confidence in its Cannabis Market Penetration and Growth

ChineseInvestors.com, Inc. (OTCQB: CIIX) participated in SeeThruEquity’s 6th Annual Microcap Investor Conference on June 1, 2017, in New York. That conference gives investors the exclusive opportunity to discover publicly traded companies with market capitalization of less than $1 billion. CIIX offers educational consulting services for Chinese investors. Most recently, it has been pursuing opportunities in the cannabis market. The goal of the company is to be a leading publicly-traded company within the nutritional industry. In addition to its online store based in the free trade zone of Shanghai, China, CIIX is building its first retail store in San Gabriel, California.…

Continue Reading

WednesdayJun 07, 2017 9:00 am

Bitcoin Currency Could Solve Banking Issues for Cannabis Industry

Though some form of cannabis is now legal in 29 states and the District of Columbia, a lack of banking options for cannabis businesses in the United States continues to force marijuana merchants to rely solely on cash transactions. This inhibition has been a major obstacle for dispensaries and other cannabis-related businesses, but the use of bitcoin technology could be the key to overcoming the roadblock. SinglePoint, Inc. (SING) (SING Profile) has announced an initiative to develop a bitcoin payment solution for the marijuana industry, providing a much-needed financial transaction option and allowing cannabis businesses to accept credit card payments…

Continue Reading

TuesdayJun 06, 2017 3:05 pm

India Globalization Capital, Inc. (NYSE: IGC) Targets Human and Veterinary Epilepsy with Innovative Cannabinoid Therapy

With about 50 million people affected worldwide, drug-resistant epilepsy, or refractory epilepsy, is a very serious condition for which a medical solution has not yet been found, but the therapeutic benefits of phytocannabinoid-based therapies for seizures have been coming under increased scrutiny lately. There is mounting evidence that cannabinoid extracts, and in particular cannabidiol (CBD), can have a positive impact on epilepsy patients and alleviate seizures, as indicated by recent research. Companies such as India Globalization Capital, Inc. (NYSE MKT: IGC) are at the forefront of discovering cannabinoid-based epilepsy treatments for humans and animals alike, by developing innovative formulations that…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000